Vnitr Lek 2013, 59(3):187-192

The benefit of pars plana vitrectomy for the resolution of complications of proliferative diabetic retinopathy

O. Chrapek*, B. Jirková, J. Šimičák, M. Šín, J. Řehák
Oční klinika Lékařské fakulty UP a FN Olomouc, přednosta doc. MUDr. Jiří Řehák, CSc., FEBO

Between 1997 and 2007, we have conducted eye surgery on 72 patients (i.e. 72 eyes) as a consequence of proliferative diabetic retinopathy complications. The patients' average age was 61; the follow-up observations were carried out over a period of one year after the surgery. When we compare the initial vision with the visual acuity measured during the last follow-up examination in the late post-operative period, i.e. one year after the surgery, we can conclude that the vision of 46 eyes (63%) had improved, 17 eyes (24%) did not show any change in vision, and the vision of nine eyes (13%) had deteriorated. Visual acuity of 1/60 (metric system) or better was found in 55 eyes (76%) during the late post-operative period; 6/60 vision or better was found in 29 eyes (40%), and four eyes (6%) showed 6/12 vision or better. If we compare the vision in the early post-operative period with the visual acuity during the last follow-up examination in the late post-operative period, we can conclude that in most cases, i.e. in 45 eyes (62.5%), the vision did not change any further during the months after the surgery, and one eye (1.5%) even showed improvement in visual acuity. It was confirmed that a positive result of pars plana vitrectomy observed in the early post-operative period may indeed persist even during the following months and years of the patient's life.

Keywords: proliferative diabetic retinopathy; pars plana vitrectomy

Received: December 23, 2012; Published: March 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chrapek O, Jirková B, Šimičák J, Šín M, Řehák J. The benefit of pars plana vitrectomy for the resolution of complications of proliferative diabetic retinopathy. Vnitr Lek. 2013;59(3):187-192.
Download citation

References

  1. Sosna T, Bouček P, Fišer I. Diabetická retinopatie. Praha: Jiří Cendelín 2001, 209-229.
  2. Karel I, Kalvodová B, Doležalová J et al. Dlouhodobé výsledky a prognóza pars plana vitrektomie u komplikací diabetické retinopatie. Čs Oftal 1987; 43: 137-144.
  3. Karel I, Kalvodová B. Pars plana vitrektomie u proliferativní diabetické retinopatie. Dlouhodobé výsledky a prognostické parametry u diabetiků operovaných v letech 1983-1989. Čs Oftal 1991; 47: 353-362.
  4. Blankenship GW. Stability of Pars Plana Vitrectomy Results for Diabetic Retinopathy Complications. A Comparison of Five-Year and Six-Month Postvitrectomy Findings. Arch Ophthalmol 1981; 99: 1009-1012. Go to original source... Go to PubMed...
  5. Rice TA, Michels RG. Long-term anatomic and functional results of vitrectomy for diabetic retinopathy. Am J Ophthalmol 1980; 90: 297-303. Go to original source... Go to PubMed...
  6. Aaberg TM. Pars plana vitrectomy for diabetic traction retinal detachment. Ophthalmology 1981; 88: 639-642. Go to original source... Go to PubMed...
  7. Barrie T, Feretis E, Leaver P et al. Closed microsurgery for diabetic traction macular detachment. Brit J Ophthalmol 1982; 66: 754-758. Go to original source... Go to PubMed...
  8. Blankenship GW. Preoperative prognostic factors in diabetic pars plana vitrectomy. Ophthalmology 1982; 89: 1246-1249. Go to original source... Go to PubMed...
  9. Hutton WL, Bernstein I, Fuller D. Diabetic traction retinal detachment. Factors influencing final visual acuity. Ophthalmology 1980; 87: 1071-1077. Go to original source... Go to PubMed...
  10. Karel I, Doležalová J, Kalvodová B et al. Pars plana vitrektomie u komplikací diabetické retinopatie. Čs Oftal 1986; 42: 393-400.
  11. Machemer R, Blankenship G. Vitrectomy for proliferative diabetic retinopathy associated with vitreous hemorrhage. Ophthalmology 1981; 88: 643-646. Go to original source... Go to PubMed...
  12. Michels RG, Rice TA, Rice EF. Vitrectomy for diabetic vitreous hemorrhage. Amer J Ophthalol 1983; 95: 12-21. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.